Research output per year
Research output per year
International and National Collaboration
Publications and projects within past five years.
-
Durable complete response after combined treatment with tumor-infiltrating lymphocytes and oncolytic adenovirus (TILT-123) in a patient with metastatic mucosal melanoma
Monberg, T. J., Kudling, T., Albieri, B., Pakola, S., Ellebaek, E., Donia, M., Eefsen, R. L., von Buchwald, C., Kistler, C., Santos, J. M., Clubb, J., Haybout, L., Westergaard, M. C. W., Quixabeira, D. C. A., Jirovec, E., Havunen, R., Sorsa, S., Cervera-Carrascon, V., Hemminki, A. & Svane, I. M., 2024, In: Immuno-oncology technology. 10 p., 100726.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Overcoming effector T cell exhaustion in ovarian cancer ascites with a novel adenovirus encoding for a MUC1 bispecific antibody engager and IL-2 cytokine
Basnet, S., Van der Heijden, M., Quixabeira, D. C. A., Jirovec, E., Grönberg-Vähä-Koskela, S. A. M., Clubb, J. H. A., Kanerva, A., Pakola, S., Haybout, L., Arias, V., Hemminki, O., Kudling, T., Zafar, S., Santos, J. M. & Hemminki, A., 2024, In: Molecular therapy. 14 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Safety, Efficacy, and Biological Data of T-Cell–Enabling Oncolytic Adenovirus TILT-123 in Advanced Solid Cancers from the TUNIMO Monotherapy Phase I Trial
Pakola, S. A., Peltola, K. J., Clubb, J. H. A., Jirovec, E., Haybout, L., Kudling, T. V., Alanko, T., Korpisaari, R., Juteau, S., Jaakkola, M., Sormunen, J., Kemppainen, J., Hemmes, A., Pellinen, T., van der Heijden, M., Quixabeira, D. C. A., Kistler, C., Sorsa, S., Havunen, R., Santos, J. M., & 2 others, 1 Sept 2024, In: Clinical cancer research. 30, 17, p. 3715-3725 11 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Syövän onkolyyttisen virushoidon ensimmäiset ensimmäisen vaiheen tulokset
Translated title of the contribution :Safety, efficacy, and biological data of T cell-enabling oncolytic adenovirus TILT-123 in advanced solid cancers from the TUNIMO monotherapy phase I trial Research output: Contribution to journal › Comment/debate › Professional
-
An oncolytic adenovirus coding for a variant interleukin 2 cytokine improves response to chemotherapy through enhancement of effector lymphocyte cytotoxicity, fibroblast compartment modulation and mitotic slippage
Pakola, S., Quixabeira, D. C. A., Kudling, T. V., Clubb, J. H. A., Grönberg-Vähä-Koskela, S., Basnet, S., Jirovec, E., Arias, V., Haybout, L., Heiniö, C., Santos, J. M., Cervera-Carrascon, V., Havunen, R., Anttila, M. & Hemminki, A., 5 Jul 2023, In: Frontiers in Immunology. 14, 13 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile